ArticleJournal of pathology and translational medicine2026

Prevalence of HER2-ultralow breast cancer in South Korea: a multicenter study by reassessment of HER2-zero cases.

Min Chong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.